| 000 | 01898 a2200589 4500 | ||
|---|---|---|---|
| 005 | 20250516095632.0 | ||
| 264 | 0 | _c20130628 | |
| 008 | 201306s 0 0 eng d | ||
| 022 | _a1000-467X | ||
| 024 | 7 |
_a10.5732/cjc.011.10469 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYing, Zhi-Tao | |
| 245 | 0 | 0 |
_aThe clinical features, therapeutic responses, and prognosis of the patients with mantle cell lymphoma. _h[electronic resource] |
| 260 |
_bChinese journal of cancer _cJul 2012 |
||
| 300 |
_a348-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCyclin D1 _xmetabolism |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 |
_aEtoposide _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Mantle-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aStem Cell Transplantation |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aVincristine _xtherapeutic use |
| 700 | 1 | _aZheng, Wen | |
| 700 | 1 | _aWang, Xiao-Pei | |
| 700 | 1 | _aXie, Yan | |
| 700 | 1 | _aTu, Mei-Feng | |
| 700 | 1 | _aLin, Ning-Jing | |
| 700 | 1 | _aPing, Ling-Yan | |
| 700 | 1 | _aLiu, Wei-Ping | |
| 700 | 1 | _aDeng, Li-Juan | |
| 700 | 1 | _aZhang, Chen | |
| 700 | 1 | _aZhu, Jun | |
| 700 | 1 | _aSong, Yu-Qin | |
| 773 | 0 |
_tChinese journal of cancer _gvol. 31 _gno. 7 _gp. 348-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5732/cjc.011.10469 _zAvailable from publisher's website |
| 999 |
_c21869766 _d21869766 |
||